Filing Flows › NRX Pharmaceuticals (NRXP) › Therapy revenue
NRX Pharmaceuticals (NRXP) Therapy revenue by quarter
NRX Pharmaceuticals' Therapy revenue was $871K in Q2 2026 (second quarter 2026), +15% from Q1 2026. Over the last 4 quarters it ranged from $152K (Q3 2025) to $871K (Q2 2026).
| Quarter | Therapy revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $871K | +15% | — |
| Q1 2026 | $760K | +8% | — |
| Q4 2025 | $702K | +362% | — |
| Q3 2025 | $152K | — | — |
Q2 2026 at a glance
NRX Pharmaceuticals, Q2 2026: revenue $1.1M, operating margin -590.8%, net loss $16.5M, operating cash flow −$8.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is NRX Pharmaceuticals' Therapy revenue?
NRX Pharmaceuticals' Therapy revenue was $871K in Q2 2026 (second quarter 2026), +15% from Q1 2026.
How has NRX Pharmaceuticals' Therapy revenue changed?
Over the last 4 quarters it ranged from $152K (Q3 2025) to $871K (Q2 2026).